Investigation of Systemic Metal Ion Concentration Following a Ceramic-on-metal Total Hip Arthroplasty
NCT ID: NCT00883805
Last Updated: 2015-09-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2009-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Metal Ion Serum Concentrations in Patients With Total Hip Replacements
NCT00156598
Metal Ions in Ceramic on Metal Total Hip Arthroplasty
NCT01437124
Whole Blood Metal Ion Concentrations in Metal-on-metal Total Hip Arthroplasty and Hip Resurfacing
NCT04585022
Short-Term Clinical Outcome of Total Hip Arthroplasty Using Larger Diameter of 4th Generation Ceramic Bearing
NCT01103882
RCT Comparing Ion Levels and Clinical Outcomes of A-Class BFH to Metal on Polyethylene Total Hip Replacement
NCT00911599
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Increased metal ion production has been documented in metal-on-metal arthroplasty articulations. There are several concerns over metal ion production. First, even though there is a decreased histiocytic response to metallic debris, a dose dependent cytotoxic response with Interleukin 6, Prostaglandin E2, and Tumor Necrosis Factor alpha persists and may cause osteolysis in the long term. Second, increased levels of cobalt, chromium and nickel has been shown to correlate with increased cancer rates in several animal models, and the carcinogenic risk in humans has not been fully elucidated as yet. Third, hypersensitivity reactions to metal ion develop in up to 25% of these patients, and 60% of patients with poorly functioning hip.
Ceramic on metal avoids many of these problems due to the improved wear characteristics. If the level of metal ion production is significantly reduced and the implant survivability is proven in long term studies, this articulation may become the preferred method.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Metal-on-Metal Articulations
Subjects will be people who have had metal-on-metal total hip arthroplasties
Blood draw
Subjects will give blood for analysis of metal ion concentrations
X-Ray of Hip
Subject will have x-ray of hip to assessment of osteolysis
Ceramic-on-Metal Articulations
Subjects will be people who have had ceramic-on-metal total hip arthroplasties
Blood draw
Subjects will give blood for analysis of metal ion concentrations
X-Ray of Hip
Subject will have x-ray of hip to assessment of osteolysis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood draw
Subjects will give blood for analysis of metal ion concentrations
X-Ray of Hip
Subject will have x-ray of hip to assessment of osteolysis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient must be able to provide consent to participate
Exclusion Criteria
* Evidence of active infections
* Patients whose occupations include welding or metal working
* A second arthroplasty performed since the initial will not be exclude, but their data will be analyzed as a subpopulation
* unwillingness to comply with rehabilitation program or inability to return for follow-up visits
* Any systemic steroid therapy within 3 months of surgery
* Subjects who are pregnant
40 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Northwell Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Daniel Grande
director:orthopaedic research
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Daniel Grande, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Feinstein Institute for Medical Research
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Feinstein Institute for Medical Research
Manhasset, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB# 07-08-105
Identifier Type: -
Identifier Source: secondary_id
GCRC 0163
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.